HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19 (2022)

First Author: Astbury S
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/imm.13450

PubMed Identifier: 35156709

Publication URI: http://europepmc.org/abstract/MED/35156709

Type: Journal Article/Review

Parent Publication: Immunology

Issue: 1

ISSN: 0019-2805